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ABTRACT
Gastrointestinal endoscopy is rapidly developing and several gastrointestinal endoscopy equipment are 
available for both diagnostic and therapeutic purposes. Proper sedation is critical in performing endoscopic 
procedures, both for patients and physicians. This consensus is used as a guideline and not as a legal standard 
in performing endoscopic services. This consensus explained the definition, indication, contraindication, and 
complication prevention during sedation. Factors affecting the need of sedation is patient factors, procedure 
factors, and sedation level. Diagnostic or therapeutic upper gastrointestinal tract endoscopy which not complicated 
can be performed with minimal sedation or moderate sedation, while deep sedation can be considered for longer 
and more complex procedures. Furthermore, assessment and selection of sedation was explained, followed 
by the guide to choose pharmacological sedation and analgesics. Currently, diazepam, midazolam, propofol, 
fentanyl, and pethidine is the most likely used sedation during gastrointestinal endoscopy, with midazolam as 
the preferred medication of choice. This consensus also explained the antidote of each drug and the recovery 
after procedure. This consensus aimed to improve gastrointestinal endoscopic procedure services in Indonesia. 
Keywords: diazepam, fentanyl, gastrointestinal endoscopy, midazolam, national consensus, pethidine, propofol, sedation
ABSTRAK
Endoskopi saluran cerna saat ini telah berkembang pesat dan berbagai peralatan telah tersedia baik untuk 
keperluan diagnostik maupun terapeutik. Sedasi yang tepat sangatlah penting selama prosedur endoskopi, baik 
untuk pasien maupun dokter. Konsensus ini menjadi petunjuk dan bukan menjadi standar baku dalam pelayanan 
endoskopi saluran cerna. Konsensus ini menjelaskan definisi, indikasi, kontraindikasi, dan pencegahan komplikasi 
dari penggunaan sedasi. Faktor yang memengaruhi pemilihan dan kebutuhan sedasi terdiri atas faktor pasien, 
faktor prosedur, dan tingkat sedasi yang diharapkan. Endoskopi saluran cerna baik untuk diagnostik maupun 
terapeutik yang tidak kompleks membutuhkan sedasi yang minimal atau sedang, sementara sedasi dalam 
dibutuhkan pada prosedur yang kompleks dan panjang. Lebih lanjut lagi, pengkajian dan penentuan kebutuhan 
sedasi dijelaskan, kemudian dilanjutkan dengan penduan memilih obat-obatan sedasi dan analgesik. Saat ini, 
diazepam, midazolam, propofol, fentanyl, dan pethidine merupakan obat sedasi yang paling sering digunakan 
dalam prosedur endoskopi saluran cerna, dengan midazolam masih menjadi obat pilihan berbagai ahli endoskopi 
saluran cerna. Konsensus ini juga menjelaskan antidotum dari tiap obat dan pemantauan pemulihan pasien 
pasca prosedur. Konsensus ini bertujuan untuk memperbaiki pelayanan endoskopi saluran cerna di Indonesia. 
Kata kunci: diazepam, endoskopi saluran cerna, fentanyl, konsensus nasional, midazolam, pethidine, propofol, sedasi
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INTRODUCTION
Gastrointestinal (GI) endoscopy is an examination 
to evaluate the structure of the upper and lower 
gastrointestinal mucosa in detail through a camera 
located at the end of the scope.1 Nowadays, 
gastrointestinal endoscopy is rapidly developing and 
several gastrointestinal endoscopy equipments are 
available, including esophagogastroduodenoscopy, 
enteroscopy (single baloon or double baloon), 
endoscopic retrograde pancreatography (ERCP), 
endoscopic ultrasonography (EUS), and colonoscopy.1,2 
The use of gastrointestinal endoscopic equipments not 
only can be used for diagnostics but also for therapeutic 
procedures.1,2
Several endoscopic procedures can be performed 
using gastrointestinal endoscopic equipment, such 
as ligation or sclerotherapy of esophageal or gastric 
varices, upper or lower gastrointestinal polypectomy, 
oesophageal dilatation either with savary spark or with 
pneumatic dilatation, pylorus dilation, stent application 
of upper or lower gastrointestinal, upper and lower 
gastrointestinal hemostasis, foreign body extraction, 
endoscopy mucosal resection (EMR), endoscopy 
submucosal disection (ESD) or fine needle aspiration 
through EUS. In the field of hepatobiliary, ERCP can be 
used for sphincterotomy procedures, stone extraction, 
and installation of common bile duct stent (CBD).1
The purpose of sedation and analgesic endoscopy is 
to reduce anxiety, discomfort in patients, reduce psychic 
trauma, and achieve optimal endoscopic examination 
results.2,3,4 The patients’ comfort depends on the skill 
of the operating doctor and supported by sophisticated 
equipment, and also no less important is the sedation 
given during the gastrointestinal endoscopic procedures. 
Furthermore, proper sedation may also assist the 
physician in performing endoscopic procedures.4 The 
sedation procedures for gastrointestinal endoscopic 
procedures in the world and especially in Indonesia 
are not the same, from no sedation, to mild sedation, to 
deep sedation/general anesthesia.2 Currently the use of 
deep sedation, in particular propofol, has been widely 
used in gastrointestinal endoscopic procedures.5,6,7 
Similarly, sedative analgesic drugs such as fentanyl 
or pethidine are also widely used.2,6 Accordingly with 
that matter, a consensus was drawn up by an agreement 
of gastrointestinal endoscopy experts representing 
all branches in Indonesia to serve as a reference in 
the daily gastrointestinal endoscopic action. This 
consensus is used as a guideline and not as a legal 
standard in performing endoscopic services.
Definition of Sedation
Sedation can be defined as drug-induced level 
of awareness suppression.3 The purpose of sedation 
and analgesia is to reduce anxiety and discomfort 
in patients, improve the quality of examination, and 
reduce patients’ memory of examination process.3 
According to guideline from American Society of 
Anesthesiologist (ASA), sedation and analgesia 
consist of a continuation of the patient's condition 
starting from minimal sedation (ansiolysis) to general 
anesthesia (Table 1).8 Changes in sedation levels 
from conscious sedation to general anesthesia can 
occur unintentionally with little change in the dose of 
sedation used.8
Factors Affecting the Need for Sedation and Degree 
of Sedation
Several things to consider in the provision of 
sedation for the procedures of gastrointestinal 
endoscopy include patient factors and procedure 
factors, are as follows: (1) Patient factors: age, health 
status, current medication, anxiety level before 
procedure, pain tolerance; (2) Procedure factors: 
degree of examination’s invasiveness, degree of 
discomfort caused by endoscopic procedure, the need 
or not for patient immobilization during the procedure, 
duration of examination; (3) Sedation level. Level 
of sedation consists of minimal sedation, moderate 
sedation, deep sedation and general anesthesia. The 
response during sedation and its effects on respiratory 
tract, ventilation and cardiovascular function can be 
seen in Table 1.3,5,9




conscious sedation Deep sedation General anesthesia 
Response Normal response with verbal 
stimulation
Responsive to verbal or 
tactile stimulation
Responsive to recurrent 
stimulation/ pain 
Unresponsive with pain 
stimulation




Spontaneous ventilation Not affected Adequate Can be inadequate Often inadequate 
Cardiovascular function Not affected Usually controlled Usually controlled Can be disturbed
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Indications, Contraindications, and Complications 
Prevention of Sedation Indication of Sedation
Rigid and flexible sigmoidoscopy, rectal 
endosonography. In this case, routine sedation is not 
required. Moderate sedation is an option for anxious 
patients, pain anticipation, or therapeutic procedures. 
Upper gastrointestinal endoscopy as well as diagnostic 
and therapeutic colonoscopy without complication may 
be done with sedation. In a complicated procedure or 
takes a long time, (e.g. ERCP, endosonography), deep 
sedation may be needed or by request of the patient.
Assessment Before and During Endoscopic 
Procedures
Assessment Before Endoscopic Procedures
Important predictors of the adverse effects of 
sedation should be obtained from anamnesis and 
physical examination prior to procedure. Several 
important predictors can be seen in Table 2.
Table 2. Contraindication of moderate to deep sedation 
administration
Absolute Relative
Patients in unstable condition: 
need to resuscitate first
Children
Uncooperative patients (e.g. 




Anticipation of the occurrence 
of intolerance to standard 
sedation
*For relative contraindications, consider anesthesiologist assistance.10
Table 2. Anamnesis and physical examination before 
endoscopic procedures3,5,9
Anamnesis Physical examination
Significant heart or lung disease Weight and body mass index
Neurologic disease, including 
a history of stroke, transient 
ischemic attack or seizure
Resting blood pressure, pulse 
rate, and breath frequency
Obesity, obstructive sleep apnea 
and other conditions affecting 
the airway such as a history of 
oropharyngeal surgery
Auscultation findings on lung 
and precordium examination
Snoring history or breath sound 
which suggestive of stridor
Physical state of the neck and 
oral cavity which can make 
positive pressure ventilation 
more difficult. Mallampati score 
is an indicator of the degree 
of difficulty of endotracheal 
intubation
Side effects reactions to 
sedation and anesthetic drugs
Use of medicines, herbal 
therapy, and recreational drugs 
Use of alcohol and cigarettes
The length of fasting performed 
by the patient
Pregnant or possibly pregnant 
patient
Prevention and Treatment of Sedation Administration 
Complications
Proper and careful dose administration especially 
for vulnerable and elderly patients is important to avoid 
cardiorespiratory depression during endoscopy. There 
is evidence that oxygen supplementation reduces 
the risk of hypoxemia during colonoscopy, although 
there is concern that when oxygen supplementation 
is given oxygen saturation levels no longer show 
ventilatory function and can mask CO2 retention. 
However, the results of anesthesiologist surveys 
in Australia show that oxygen supplementation is 
routinely done. Expertise in dealing with airway 
obstruction and apnea is important to be mastered, 
including chin lift, jaw thrust, oropharyngeal 
tube installation, and nasopharyngeal tube. For a 
dangerous and lenghty respiratory condition requiring 
bag & mask ventilation. Antidotums such as naloxone 
and flumazenil are used when necessary as indicated. 
Further life support measures such as the use of 
laryngeal mask and endotracheal intubation are rarely 
needed in an outpatient setting.9 For patients who 
have hypotension due to sedation drugs are given 
intravenous fluids. For endoscopic procedures which 
take place in hospitals, it is recommended to provide 
emergency rescue access.9
Assessment Before Endoscopic Procedures
In order for a safe endoscopy procedure to take 
place, careful assessment is required. Patients should 
always be under clinical supervision with particular 
attention to respiratory movement and response to 
verbal and tactile stimulation. At least one member 
of the endoscopic team specifically monitors the 
endoscopy patient. The person may be a medical 
practitioner trained on sedation and monitoring or 
a nurse working under endoscopist supervision. In 
addition, the pulse oximetry is measured continuously, 
the blood pressure is measured periodically, and the 
pulse rate is measured before, during, and after the 
procedure. Then all the measurement results are 
documented. Other monitoring techniques such as 
capnography which are more sensitive hypoventilation 
indicators than pulse oximetry or visual inspection 
can be used for patients with higher risk. The use of 
capnography has been shown to decrease the risk of 
desaturation when used during ERCP and EUS. EEGs 
have not been shown to benefit more in endoscopic 
procedures.9
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Selection and Authority of Sedation, Selection of 
Sedation for Endoscopy
Generally, diagnostic or therapeutic upper 
gastrointestinal tract endoscopy which not complicated 
can be performed with minimal sedation or moderate 
sedation. Deep sedation can be considered for longer 
and more complex procedures, such as ERCP and 
EUS.1,2,4. Deep sedation or general anesthesia should 
be considered in patients who are difficult to handle 
with moderate sedation and are thought to be less 
responsive to sedation. Patients who are less responsive 
are patients who consume narcotics, benzodiazepines, 
alcohol, or long-term neuropsychiatric treatment.1 
In the daily practice of gastrointestinal endoscopic 
procedures, several things which can be done, among 
others: without sedation, with local anesthesia, with 
sedation and analgesic.3
Without Sedation
Endoscopy with a small diameter (less than 6 mm) 
or transnasal may increase upper gastric endoscopic 
tolerance so it can be performed without sedation. 
Generally, topical anesthesia is used for endoscopy 
without sedation. Older patients, men, patients who are 
not anxious, or patients without a history of abdominal 
pain may have better tolerance to undergo upper 
gastrointestinal endoscopy or colonoscopy should be 
considered for minimal or no sedation. For endoscopy 
without sedation, the type and level of monitoring 
should be adjusted per individual.
Topical Anesthesia
Topical anesthesia of pharyngeal spray with 
lidocaine, tetracaine, and benzocaine is often used 
for anesthetic purposes during upper gastrointestinal 
endoscopy. One meta-analysis study showed that 
the use of pharyngeal anesthesia together with 
intravenous or intramuscular sedation facilitates 
endoscopic examination or improves patient tolerance. 
Topical anesthesia is known to be associated with 
some serious side effects, including aspiration, 
bronchial asthma relapse, anaphylactoid reaction, and 
methemoglobinemia. Although these things are rare, 
they still need to be waried.
Sedation and Analgesia
Selection of sedation agents is highly dependent on 
the operator and based on maximizing patient comfort 
while minimizing risk. The choice of sedation generally 
consists of administering benzodiazepines alone or 
in combination with opiates to give a synergistic 
effect. The most commonly used benzodiazepines 
are midazolam and diazepam. The efficacy of both is 
comparable, but endoscopic prefer midazolam because 
of its faster action time, shorter duration of action, 
and high amnestic effects. Opioids, such as pethydine 
and fentanyl, have analgesia and sedation effects. 
Fentanyl has a faster action and clearance time and a 
lower incidence of nausea. Compared with traditional 
sedation (benzodiazepines), sedation using propofol 
provides similar side effects, better post-procedure 
patient satisfaction, decreases sedation time, and 
speeds recovery. In terms of side effects, propofol can 
cause hypoventilation, hypotension, and bradycardia 
are relatively common, but severe side effects are very 
rare. The need for sedation in endoscopic procedures 
(Table 3).
The Authority of Propofol Administration is in the 
Hand of Anesthesiologist
Administration of sedation for low-risk patients 
may be performed by non-anesthesiologists who have 
been certified specialized in the administration of 
propofol for gastrointestinal endoscopy.2,3,5,12









Esofagogastroduodenoscopy v v v v
Colonoscopy v v v v
Savary bougie/pneumatic baloon - v v v
Upper gastrointestinal polypectomy and lower gastrointestinal tract - v v v
Upper and lower gastrointestinal tract bleeding v v v v
Diagnostic or theurapetic ERCP (sphincterotomy, stone extraction, stent CBD) v v v
PEG (SCBS)/gastrostomy - v v v
Foreign body extraction in upper or lower gastrointestinal tract v v v v
Ligation or STE esophageal varices (VE) v v - v
STE gastric varises v v - v
Enteroscopy: single balloon or
double balloon
- v v v
Diagnostic or theurapetic EUS v v v v
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The Authority of Deep Sedation and General Anesthesia 
Administration is in the Hand of Anesthesiologist 
Sedation Administration Procedure Including 
Analgesic for Endoscopy
Administration of sedation in endoscopic procedures 
is as needed, depending on the judgment of the 
endoscopic practitioner and upon the patient's request. 
In the implementation, some of the following points 
need to be considered:
Implementation
Personnel
There is one endoscopic nurse who monitors the 
patient continuously.
Patient preparation and monitoring
Intravenous access is needed for sedation and using 
venous catheters. It is recommended to provide oxygen 
supplementation due to frequent oxygen desaturation 
in patients breathing with room oxygen alone. Patient 
monitored using pulse oximetry and, if available, 
automatic noninvasive blood pressure measurements 
are done (at baseline and every 3-5 min intervals). 
Patients with a history of heart or lung disease should 
have a continuous electrocardiography.5,8 Patients with 
dehydration, obesity, and old age need special attention 
before the administration of sedation drugs.
Level of sedation
Simple endoscopic procedures may be performed 
with mild to moderate sedation. More complicated 
(EUS and ERCP) or longer procedures need to be 
considered the use of deep sedation or anesthesia.3,5,8,9 
If endoscopist requires deep sedation, it should be 
considered consultation to a trained anesthesiologist/ 
non-anestesiologist. If endoscopist requires general 
anesthesia, it should be consulted to an anesthesiologist.
Special attention
The administration of sedation and analgesia 
should consider the various organ disorders which 
have occurred in patients, among others: liver function 
disorders, kidney function, lung function, heart 
function and geriatric patients.3,5
Antidotum and cardiopulmonary resuscitation 
equipment
Antidotum (naloxone and flumazenil) and 
cardiopulmonary resuscitation equipment should be 
available in the action room of endoscopy procedure.5
Recovery period
Observations performed by endoscopic nurses 
include assessment of consciousness, hemodynamics, 
and respiration. Transfer/discharge of patient can be 
done after fulfilling Aldrete criterion. Outpatients are 
not allowed to bring their own vehicle/drive up to 24 
hours after the procedure.
Observation of Endoscopy Procedure
Observation includes all patient managements, 
namely: (1) Vital signs assessed by regular intervals 
(oxygen saturation, heart rate and blood pressure); 
(2) Complications due to sedation and treatment; 
(3) Check list criteria for discharge.5
Pharmacological Characteristics of Sedation and 
Analgesic Drugs for Endoscopy
Currently the drugs still used in gastrointestinal 
endoscopic measures are diazepam, midazolam, 
propofol, fentanyl and pethidine. The characteristics 
of these drugs among others: 
Diazepam
Pharmacokinetics
Dose of sedation is 0.04-0.2 mg/kg body 
weight. Distribution: easily soluble in the lipid 
and penetration into the blood brain barrier occurs 
quickly. Biotransformation: converted in the liver 
into water-soluble end product. Excretion: especially 
through urine. The enterohepatic circulation causes 
secondary peak levels in plasma 6-12 hours after 
administration.14,15
Table 4. Anesthesia recovery period from Aldrete13
The value of 
clinical feature
2 1 0
Consciousness Conscious, good orientation Can be awakened Can not be awakened
Color Pink, O2 required for O2 saturation> 92% Pale/ blackish need O2 for O2 
saturation > 90%
Cyanosis, with O2 saturation < 90%
Activity Four extremities can be moved Two extremities can be moved The extremity does not move
Respiration Can breath and cough Shallow breath, shortness of breath Apneu or obstruction
Cardiovascular Blood pressure changed < 20% Blood pressure changed 20-30% Blood pressure changed 50%
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Effects on organ systems
Cardiovascular: minimal suppressive effect although 
at induction dose. Arterial blood pressure, cardiac 
output, and peripheral vascular resistance usually 
slightly decrease, while heart rate increases. Respiration: 
decreases the ventilatory response to CO2. Central nervous 
system (SSP): lowers oxygen consumption in the brain, 
blood flow to the brain, and intracranial pressure.14,15
Midazolam
Pharmacokinetics
Absorbtion: usually given intravenously with 
sedation dose of 0.01-0.1 mg/kg body weight. Injection 
of midazolam causes minimal venous irritation, 
sometimes can cause thrombophlebitis. Distribution: 
soluble in water at low pH, but imidazole ring causes 
increased solubility in lipids. The maximum effect is 
achieved after about 2 minutes and gives 30 minutes 
of sedation. Elderly patients tend to be more sensitive 
and recover longer. Biotransformation: Midazolam is 
converted in the liver into water-soluble end product. 
Its half-life is about 2 hours with a clearance of 6-11 
mL/min per kg. Excretion: especially excreted in urine. 
Kidney failure can prolong the period of sedation.14,15
Effects on organ systems
Cardiovascular: lowers blood pressure and peripheral 
vascular resistance as well as changes in heart rate 
variability. The effect in decreasing blood pressure is 
greater than diazepam. Respiration: lowers the ventilation 
response to CO
2
. CNS: lowers oxygen consumption in the 
brain, blood flow to the brain, and intracranial pressure. 
Cause antegrad amnesia. Has a mild muscle relaxant 
effect. It has no direct analgesic effect.14,15
Propofol
Pharmacokinetics
Absorbsi: can only be given intravenously for 
induction of anesthesia and moderate to deep sedation. 
Propofol administration causes pain during injection, 
which can be reduced by administering lidocaine 
and choosing a large antecubital vein. The dose is 
reduced for the elderly and the concurrent use of 
other sedatives. Generally, the onset of action is 30-60 
seconds sedation, with action duration of 4-8 minutes. 
Distribusi: highly soluble in lipid, so that it has short 
onset of action. The recovery time of a single bolus is 
also very fast due to very short half-life distribution (2-8 
minutes). Biotransformasi: clearance of propofol takes 
place in the liver as well as extrahepatic, thus speeding 
up the recovery period after IV administration. The 
conjugate is an inactive metabolite. Pharmacokinetics 
of propofol appears to be not affected by moderate 
cirrhosis. Ekskresi: propofol metabolites are excreted 
in the urine, but chronic kidney disease does not affect 
the clearance of propofol itself.14,15
Effects on organ systems
Cardiovascular: lowers arterial blood pressure 
due to decreased systemic vascular resistance 
(inhibition of sympathetic vasoconstrictor activity), 
cardiac contractility, and preload. Factors which 
exacerbate hypotension, among others: large doses, 
rapid injections, and old. Propofol significantly 
disrupts normal baroreflex response to hypotension, 
particularly in normocarbia or hypocarbia conditions. 
Patients with impaired ventricular function may 
experience significant decrease in cardiac output due to 
decreased ventricular filling pressure and contractility. 
Respirasi: at induction doses, causes severe respiratory 
depression to apnea. In the conscious patient, infusion 
of propofol (subanesthetic dose) inhibits breathing 
impulse from hypoxic states and depress normal 
responses to hypercarbia. Propofol can cause release 
of histamines, but the wheezing incidence in asthma 
and nonasmic patients is quite rare and therefore not 
contraindicated. SSP: lowers blood flow to the brain 
and intracranial pressure. Antiemetic effect appears 
when the concentration in the blood reaches 200 ng/
mL so it is recommended for outpatients.14,15 
Propofol Medium Chain Triglycerides/Long Chain 
Triglycerides (MCT/LCT) (Propofol Lipuro®)
Propofol MCT/LCT has some advantages compared 
to propofol LCT (propofol original) which usually 
being used, among others: (1) Pain is proportional to 
the original propofol that has been added lidocaine, 
but has an equivalent effect16,17,18 ; (2) Pharmacokinetic 
profile of MCT / LCT is better than LCT, namely: rapid 
clearance, reduced immunological disorders, reduced 




Absorption: absorption occurs rapidly with peak 
plasma levels reached in about 20-60 minutes. 
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Distribution: Pethidin has a strong bond with 
proteins, while the bonds with fat are of low affinity. 
Biotransformation: undergoes biotransformation in 
the liver with a half-life of about 3 hours. In patients 
with cirrhosis of the liver, bioavailability increases by 
80% and its half-life is elongated. Excretion: the final 
product is eliminated by the kidneys, a small portion 
undergoes biliary excretion.
Effects on organ systems
Cardiovascular: Pethidin increases heart rate and 
decreases cardiac contractility. In some individuals, 
it triggers the release of histamine which causes a 
great decrease in systemic vascular resistance and 
arterial blood pressure. Respiration: causes respiratory 
depression and in susceptible people, can cause 
histamine-related bronchospasm. CNS: sometimes 
causes CNS excitation characterized by tremors, 
muscle twitches, and seizures. Gastrointestinal: 
Opioids generally slows gastric emptying by decreasing 
peristalsis. There may be biliary colic due to opioid-
induced contractions in the Oddi sphincter.14,15
Fentanyl
Pharmacokinetics
Single dose of fentanyl has duration of 30 minutes. 
Distribution: distribution in the body takes place 
quickly, which is 5-20 minutes. High solubility in 
fat causes rapid onset of action and short duration of 
action. Biotransformation: converted into an inactive 
end product. Excretion: excreted in the urine and 
partially excreted with bile. Enterohepatic recirculation 
may occur up to 4 hours after the last IV dose.
Effects on organ systems
Cardiovascular: Administration in high doses 
causes vagus-mediated bradycardia. Not suppresses 
contractility of heart muscle. However, blood pressure 
may drop because of bradycardia, venodilation, 
and decreased sympathetic reflex. Respiration: 
suppress respiration rate. Increases resting PaCO2 
and dulls the response to CO2 challenge, causes CO2 
response curve decreases to the right. Decreases the 
bronchoconstrictive response to airway stimulation, 
such as intubation. CNS: reduces oxygen consumption 
in the brain, cerebral blood flow, and intracranial 
pressure, but the effect is milder than benzodiazepine. 
Stimulation of medulla CTZ causes a high incidence 
of nausea and vomiting. Gastrointestinal: slows gastric 
emptying by lowering peristalsis. Biliary colic may 
be occurred due to contractions of Oddi sphincter.14,15
REFERENCES
1. Wong-Kee-Song LM, Topazian M. Gastrointestinal endoscopy. 
In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, 
Jameson JL, eds. Harrison’s Principles of Internal Medicine. 
17th
 
ed. New York: McGraw Hill 2008.p.1836-47.
2. Clarke AC, Chiragakis L, Hillman LC, Kaye GL. Sedation for 
endoscopy: the safe use of propofol by general practitioner 
seditionists. MJA 2002;176:159-62.
3. The Standards of Practice Committee of the American Society 
for Gastrointestinal Endoscopy. Sedation and anesthesia 
in gastrointestinal endoscopy. Gastrointestinal Endoscopy 
2008;68:815-26.
4. Gašparović S, Rustemović N, Opačić M, Premužić M, 
Korušić A, Božikov J, et al. Clinical analysis of propofol 
deep sedation for 1,104 patients undergoing gastrointestinal 
endoscopic procedures: a three year prospective study. World 
J Gastroenterol 2006;12:327-30.
5. Dumonceau JM, Riphaus A, Aparicio JR, Beilenhoff U, Knape 
JTA, Ortmann M, et al. European Society of Gastrointestinal 
Endoscopy, European Society of Gastroenterology and 
Endoscopy Nurses and Associates, and the European 
Society of Anaesthesiology guideline: non-anesthesiologist 
administration of propofol for gastrointestinal endoscopy. 
Endoscopy 2010;42:960-74.
6. Heuss LT, Froehlich F, Beglinger C. Changing patterns of 
sedation and monitoring practice during endoscopy: results of 
a nationwide survey in switzerland. Endoscopy 2005;37:161-6.
7. Cohen LB, Wecsler JS, Gaetano JN, et al. Endoscopic sedation 
in the United States: results from a nationwide survey. Am J 
Gastroenterol 2006;101:967-74.
8. Thomson A, Andrew G, Jones DB. Optimal sedation for 
gastrointestinal endoscopy: review and recommendations. J 
Gastroenterol Hepatol 2010;25:469-78.
9. Gross JB, Bailey PL, Connis RT, Coté CJ, Davis FG, Epstein 
BS, et al. Practice guidelines for sedation and analgesia by 
nonanesthesiologists. Anesthesiology 2002;96:1004-17.
10. Drossman DA, Grimm IS, Shaheen NJ. Handbook of 
Gastroenterologic Procedures. 4th
 
ed. Williams & Wilkins 2005.
11. Chin NM, Tai HY, Chin MK. Intravenous sedation for upper 
gastrointestinal endoscopy: midazolam vs propofol. Singapore 
Med J 1992:33;478-80.
12. Byrne MF, Chiba N, Singh H, Sadowski DC. Propofol use for 
sedation during endoscopy in adults: A Canadian Association 
of Gastroenterology position statement. Can J Gastroenterol 
2008;22:457-9.
13. Morgan GE, Mikhail MS, Murray MJ. Postanesthesia care. 
Clinical Anesthesiology. 4th ed. New York: McGraw Hill 
2006.p.936-50.
14. Morgan GE, Mikhail MS, Murray MJ. Non-volatile anesthetic 
agents. Clinical Anesthesiology. 4th ed. New York: McGraw 
Hill 2006.p.200-2.
15. Evers AS, Crowder CM, Balser JR. General anesthetics. In: 
Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gillman’s 
the pharmacological basis of therapeutics. 11th ed. New York: 
McGraw Hill 2006.p.341-68.
16. Doenicke AW, Roizen MF , Rau J , O'Connor M, Kugler J, 
Klotz U, Babl J. Pharmacokinetics and pharmacodynamids 
of propofol in new solvent. Anesth Anaig 1997;83:1399-
403.p.341-68.
Volume 18, Number 2, August 2017 111
National Consensus on the Use of Sedation Drugs in the Gastrointestinal Endoscopic Procedures
17. Kam E, Abdul-Latif MS, McCluskey A. Comparison of 
propofol lipuro with propofol mixed with lidocaine 10 mg on 
propofol injection pain. Anaesthesia 2004;59:1167-9.
18. Rau J, Roizen MF, Doenicke AW, Alfred W, O’Connor MF, 
Strohschneider Ursula. Propofol in an emulsion of long- and 
medium-chain triglycerides: the effect on pain. Anesth Analg 
2001;93:382-4.
19. Wycklmayr M, Rett K, Dietze G, Mehnert H. Comparison 
of metabolic clearance rates of MCT/LCT and LCT lipid 
emulsions in diabetics. JPEN 1988;12:68-71.
20. Barr J. Propofol: A new drug for sedation in the intensive care 
unit. Int Anesthesiol Clin 1995;33:131-54.
21. Smyrniotis VE, Kostopanagiotou GG, Arkadopoulos NF, 
Theodoraki KA, Kotsis TE, Lambrou AT, Vassiliou JG. 
Long-chain vs. Medium-chain lipids in acute pancreatitis 
complicated by ARDS: effects on pulmonaryhemodynamics 
and gas exchange. Clin Nutr 2001;20:139-43.
